These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24361627)

  • 1. Delivering pediatric HIV care in resource-limited settings: cost considerations in an expanded response.
    Tolle MA; Phelps BR; Desmond C; Sugandhi N; Omeogu C; Jamieson D; Ahmed S; Reuben E; Muhe L; Kellerman SE;
    AIDS; 2013 Nov; 27 Suppl 2():S179-86. PubMed ID: 24361627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The costs of treating HIV-infected children in Abidjan, Ivory Coast, 1996-1997].
    Giraudon I; Leroy V; Msellati P; Elenga N; Ramon R; Welffens-Ekra C; Dabis F
    Sante; 1999; 9(5):277-81. PubMed ID: 10657769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equity and efficiency in scaling up access to HIV-related interventions in resource-limited settings.
    Cleary S
    Curr Opin HIV AIDS; 2010 May; 5(3):210-4. PubMed ID: 20539076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the variation in costs among HIV primary care providers.
    Gilman BH; Green JC
    AIDS Care; 2008 Oct; 20(9):1050-6. PubMed ID: 18825514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizing the opportunity to capitalise on the growing access to HIV treatment to expand HIV prevention.
    Gayle H; Lange JM
    Lancet; 2004 Jul 3-9; 364(9428):6-8. PubMed ID: 15234835
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of mother-to-child transmission services as a gateway to family-based human immunodeficiency virus care and treatment in resource-limited settings: rationale and international experiences.
    Abrams EJ; Myer L; Rosenfield A; El-Sadr WM
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S101-6. PubMed ID: 17825640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tackling HIV in resource poor countries.
    Mukherjee JS; Farmer PE; Niyizonkiza D; McCorkle L; Vanderwarker C; Teixeira P; Kim JY
    BMJ; 2003 Nov; 327(7423):1104-6. PubMed ID: 14604937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy in resource-poor settings: scaling up inequalities?
    Egger M; Boulle A; Schechter M; Miotti P
    Int J Epidemiol; 2005 Jun; 34(3):509-12. PubMed ID: 15941732
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm.
    Moatti JP; N'Doye I; Hammer SM; Hale P; Kazatchkine M
    Nat Med; 2003 Dec; 9(12):1449-52. PubMed ID: 14647513
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in combination with efavirenz, in antiretroviral-naive, HIV-1-infected patients.
    Sánchez-de la Rosa R; Herrera L; Moreno S
    Clin Ther; 2008 Feb; 30(2):372-81. PubMed ID: 18343275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMMENTARY: understanding the benefits of pediatric anti-retroviral treatment in resource-limited settings.
    Hetherington S
    Pediatr Infect Dis J; 2009 Jan; 28(1):41-2. PubMed ID: 19057455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs.
    Menzies NA; Berruti AA; Berzon R; Filler S; Ferris R; Ellerbrock TV; Blandford JM
    AIDS; 2011 Sep; 25(14):1753-60. PubMed ID: 21412127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings.
    Schneider K; Puthanakit T; Kerr S; Law MG; Cooper DA; Donovan B; Phanuphak N; Sirisanthana V; Ananworanich J; Ohata J; Wilson DP
    AIDS; 2011 Jun; 25(9):1143-51. PubMed ID: 21505319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing HIV treatment programs.
    Bautista-Arredondo S; Martz TE; Wirtz VJ; Bertozzi SM
    Curr Opin HIV AIDS; 2010 May; 5(3):232-6. PubMed ID: 20539079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global progress in PMTCT and paediatric HIV care and treatment in low- and middle-income countries in 2004-2005.
    Luo C; Akwara P; Ngongo N; Doughty P; Gass R; Ekpini R; Crowley S; Hayashi C
    Reprod Health Matters; 2007 Nov; 15(30):179-89. PubMed ID: 17938083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
    Quentin W; König HH; Schmidt JO; Kalk A
    Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment.
    Kline MW
    Pediatrics; 2006 Apr; 117(4):1388-93. PubMed ID: 16585337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
    Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
    AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding and mitigating HIV-related resource-based stigma in the era of antiretroviral therapy.
    Holmes K; Winskell K
    AIDS Care; 2013; 25(11):1349-55. PubMed ID: 23394104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The marriage of science and optimized HIV care in resource-limited settings.
    Calmy A; Pizzocolo C; Pizarro L; Brücker G; Murphy R; Katlama C;
    AIDS; 2008 Nov; 22(17):2227-30. PubMed ID: 18981761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.